This morning Sarepta Therapeutics put out a press release detailing the results of a drug that actually seems to help boys with muscular dystrophy walk farther on a sixminutewalktest.
The reason to be optimistic is simple: Both the Wyeth and PTC drugs failed to show a benefit in much larger studies on the same sixminutewalktest on which eteplirsen showed a six-minute benefit.